novel inducers of apoptosis in double-refractory cll cells
Published 8 months ago • 100 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:54
novel treatment strategies in t-cell lymphomas
-
3:33
a novel composite endpoint of toxicity and pfs in patients with r/r fl treated with axi-cel
-
3:51
novel developments in relapsed/refractory hl: checkpoint inhibitors, bispecifics and car-t cells
-
1:20
novel testing techniques in scd: cell-by-cell magnetization analysis
-
1:22
protacs: potential novel agents for the treatment of cll
-
2:33
identifying novel biomarkers and advancing the classification system in cll
-
18:51
is there scientific proof we can heal ourselves? | lissa rankin, md | tedxamericanriviera
-
10:43
immunotherapy and lymphoma treatment
-
11:17
bmt update: haplo-identical transplant
-
0:49
exploring novel treatment strategies for ph-like all
-
3:01
novel promising agents and clinical trials in amyloidosis
-
4:27
insights into a novel murine model being used to investigate the pathophysiology of icans
-
2:29
epitope editing enables the use of novel immunotherapies for aml
-
2:00
associated toxicities of novel therapies for cll
-
2:36
novel non-immunological agents currently under investigation for cll
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
1:17
novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax
-
2:06
managing relapsed all: the role of novel cellular therapies & importance of conditioning regimens
-
2:37
allo-hsct for cll in the era of novel agents
-
1:21
novel approaches to harnessing the immune system in lymphoma
-
1:33
cellular and non-cellular immunotherapies in cll
-
1:25
a-hipi, a novel prognostic model for advanced hl & outcomes of elderly patients with hl in australia